跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Strattera - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Strattera
Approved
STANDARD
Strattera
Lilly del Caribe Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0252334407fb7bd9
Company
Lilly del Caribe Inc.
Type
Standard
Approval Details
Approval Id
0252334407fb7bd9
Drug Approval Philippines Name
Strattera
Product Name
Strattera
Registration Number
DR-XY44709
Brand Name
Strattera
Generic Name
Atomoxetine (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
18 mg
Manufacturer
Lilly del Caribe Inc.
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Issuance Date
24 July 2020
Expiry Date
10 July 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0252334407fb7bd9
Type
Standard
Back to Philippines FDA Approvals